[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![Cytokinetics Inc. Graphic](https://lunarcrush.com/gi/w:26/t:$cytk.png) Cytokinetics Inc. (CYTK)

Cytokinetics Inc. (CYTK) is facing negative market sentiment despite positive data and anticipation of FDA approval. Several social media users are discussing the stock, with some reporting gains.

### About Cytokinetics Inc.
Cytokinetics Inc. (CYTK) is a healthcare company focused on the development of muscle activators.  
Cytokinetics Inc. uses the ticker $CYTK for trading. Listed in the [Stocks](/list/stocks) and  category within the [Healthcare](/list/stocks/healthcare) sectors.

### Insights [#](/topic/$cytk/insights)
- Cytokinetics Inc. (CYTK) galaxy score™ is up XXXXX% from the previous week.
- Cytokinetics Inc. entered the top XX AltRank™ for the first time 

### Price: $XXXXX [#](/topic/$cytk/close)
---
![Price Line Chart](https://lunarcrush.com/gi/w:600/t:$cytk/c:line/m:close.svg)  
[Price 24-Hour Chart Data](/topic/$cytk/time-series/close.tsv)  
The price is near a 52-week low, likely due to negative market sentiment offsetting positive anticipation of FDA approval and recent positive efficacy data.  

| 24-Hour | 7-Day | 30-Day |
| ------- | ----- | ------ |
| -XXXX%  | XXXX% | XXXXX% |

**1-Year High**: $XXXXX on 2024-07-30  
**1-Year Low**: $XXXXX on 2025-05-15  
  
  
### AltRank: XXXXX [#](/topic/$cytk/alt_rank)
---
![AltRank Line Chart](https://lunarcrush.com/gi/w:600/t:$cytk/c:line/m:alt_rank.svg)  
[AltRank 24-Hour Chart Data](/topic/$cytk/time-series/alt_rank.tsv)  
Cytokinetics Inc. (CYTK) is currently AltRank #1,934 based on combined combined social and market metrics
**Daily Average**: XXX  
**1 Week**: XXXXX +1,538  
**1 Month**: XXXXX +1,321  
**6 Months**: XXXXX +1,365  
**1 Year**: XXXXX +1,083  
**1-Year High**: XXXXX on 2025-06-27  
**1-Year Low**: X on 2024-12-22  
  
  
### Galaxy Score: XXXXX [#](/topic/$cytk/galaxy_score)
---
![Galaxy Score Line Chart](https://lunarcrush.com/gi/w:600/t:$cytk/c:line/m:galaxy_score.svg)  
[Galaxy Score 24-Hour Chart Data](/topic/$cytk/time-series/galaxy_score.tsv)  
**Current Value**: XXXXX  
**Daily Average**: XX  
**1 Week**: XX +7  
**1 Month**: XX -X  
**6 Months**: XX no change  
**1 Year**: XX +9  
**1-Year High**: XX on 2024-11-18  
**1-Year Low**: X on 2024-12-02  
  
  
### Engagements: XXXXX [#](/topic/$cytk/interactions)
---
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$cytk/c:line/m:interactions.svg)  
[Engagements 24-Hour Chart Data](/topic/$cytk/time-series/interactions.tsv)  
**Current Value**: XXXXX  
**Daily Average**: XXXXXX  
**1 Week**: XXXXXX -XX%  
**1 Month**: XXXXXXX -XX%  
**6 Months**: XXXXXXXXX -XXXX%  
**1 Year**: XXXXXXXXX -XX%  
**1-Year High**: XXXXXX on 2025-01-25  
**1-Year Low**: XXX on 2025-03-30  

| Social Network | X     |
| -------------- | -     |
| Engagements    | XXXXX |
  

  
  
### Mentions: XX [#](/topic/$cytk/posts_active)
---
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$cytk/c:line/m:posts_active.svg)  
[Mentions 24-Hour Chart Data](/topic/$cytk/time-series/posts_active.tsv)  
**Current Value**: XX  
**Daily Average**: XXX  
**1 Week**: XXX -XX%  
**1 Month**: XXX +126%  
**6 Months**: XXXXX -XX%  
**1 Year**: XXXXX -XX%  
**1-Year High**: XXX on 2025-01-03  
**1-Year Low**: XX on 2024-07-31  

| Social Network | X   |
| -------------- | -   |
| Mentions       | XXX |
  

  
  
### Creators: XX [#](/topic/$cytk/contributors_active)
---
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$cytk/c:line/m:contributors_active.svg)  
[Creators 24-Hour Chart Data](/topic/$cytk/time-series/contributors_active.tsv)  
XX unique social accounts have posts mentioning Cytokinetics Inc. (CYTK) in the last XX hours which is down XX% from XX in the previous XX hours
**Daily Average**: XX  
**1 Week**: XXX -XX%  
**1 Month**: XXX +262%  
**6 Months**: XXXXX +40%  
**1 Year**: XXXXX +114%  
**1-Year High**: XXX on 2025-01-03  
**1-Year Low**: XX on 2024-07-31  

The most influential creators that mention Cytokinetics Inc. in the last XX hours

| Creator                                            | Rank | Followers | Posts | Engagements |
| -------                                            | ---- | --------- | ----- | ----------- |
| [@BPharmCatalyst](/creator/twitter/BPharmCatalyst) | X    | XXXXXX    | X     | XXX         |

[View More](/list/creators/$cytk/100)
  
  
### Sentiment: XX% [#](/topic/$cytk/sentiment)
---
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$cytk/c:line/m:sentiment.svg)  
[Sentiment 24-Hour Chart Data](/topic/$cytk/time-series/sentiment.tsv)  
**Current Value**: XX%  
**Daily Average**: XX%  
**1 Week**: XX% -XX%  
**1 Month**: XX% +8%  
**6 Months**: XX% +15%  
**1 Year**: XX% -X%  
**1-Year High**: XXX% on 2024-07-21  
**1-Year Low**: XX% on 2025-03-14  

**Most Supportive Themes**
- **Strength Meter Maps:** (10%) Users are discussing Cytokinetics Inc. (CYTK) using "Strength Meter Maps", providing positive commentary and supporting the stock with technical analysis.
- **Cytokinetics Presents New SEQUOIA-HCM Analyses:** (15%) Cytokinetics presents new SEQUOIA-HCM analyses at ESC Heart Failure 2025, showing consistent Aficamten Efficacy, which is being met with positive reactions, with a focus on potential FDA approval.
  
**Most Critical Themes**
- **General Market Sentiment:** (70%)  General negative market sentiment is influencing commentary about Cytokinetics Inc. (CYTK).
  
Network engagement breakdown:  
| Network | Positive | %   | Neutral | %   | Negative | %   |
| ------- | -------- | -   | ------- | -   | -------- | -   |
| X       | XXX      | XX% | XXXXX   | XX% | XXXXX    | XX% |
|         |          |     |         |     |          |     |
| Total   | XXX      | XX% | XXXXX   | XX% | XXXXX    | XX% |
  

  
  
### Social Dominance: XXXXXXX% [#](/topic/$cytk/social_dominance)
---
![Social Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$cytk/c:line/m:social_dominance.svg)  
[Social Dominance 24-Hour Chart Data](/topic/$cytk/time-series/social_dominance.tsv)  
**Current Value**: XXXXXXX%  
**Daily Average**: XXXXX%  
**1 Week**: XXXXXXX% +0.0004599999999999986%  
**1 Month**: XXXXX% -XXXXX%  
**6 Months**: XXXXX% -XXXXX%  
**1 Year**: XXXXX% -XXXXXXXXXXXXXXXXXXXXX%  
**1-Year High**: XXXXX% on 2024-11-20  
**1-Year Low**: XXXXXX% on 2024-07-31  
  
  
### Market Dominance: XXXXXXX% [#](/topic/$cytk/market_dominance)
---
![Market Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$cytk/c:line/m:market_dominance.svg)  
[Market Dominance 24-Hour Chart Data](/topic/$cytk/time-series/market_dominance.tsv)  
**Current Value**: XXXXXXX%  
**Daily Average**: X%  
**1-Year High**: XXXXX% on 2024-09-09  
**1-Year Low**: XXXXXXX% on 2025-07-19  
  
  
### Market Cap: $XXXXXXXXXXXXX [#](/topic/$cytk/market_cap)
---
![Market Cap Line Chart](https://lunarcrush.com/gi/w:600/t:$cytk/c:line/m:market_cap.svg)  
[Market Cap 24-Hour Chart Data](/topic/$cytk/time-series/market_cap.tsv)  
**Current Value**: $XXXXXXXXXXXXX  
**Daily Average**: $XXXXXXXXXXXXX  
**1 Week**: $XXXXXXXXXXXXX +$0.38%  
**1 Month**: $XXXXXXXXXXXXX +$14%  
**6 Months**: $XXXXXXXXXXXXX -$18%  
**1 Year**: $XXXXXXXXXXXXX -$24%  
**1-Year High**: $XXXXXXXXXXXXX on 2024-11-11  
**1-Year Low**: $XXXXXXXXXXXXX on 2025-05-15  

**Top assets mentioned**
In the posts about Cytokinetics Inc. in the last XX hours

[Bitcoin Incognito (XBI)](/topic/$xbi)
[Sarepta Therapeutics, Inc. (SRPT)](/topic/$srpt)
[StoneCo Ltd. Class A Common Shares (STNE)](/topic/$stne)
[SuperRare (RARE)](/topic/$rare)
[Merck & Co., Inc. (MRK)](/topic/$mrk)
[Akropolis (AKRO)](/topic/$akro)
[Sarepta Therapeutics, Inc. (SRPT)](/topic/sarepta-therapeutics-inc)
[Dyne Therapeutics, Inc. Common Stock (DYN)](/topic/$dyn)
[Healthpeak (DOC)](/topic/$doc)

**Top topics mentioned**
In the posts about Cytokinetics Inc. in the last XX hours

[$xbi](/topic/$xbi), [$srpt](/topic/$srpt), [stocks healthcare](/topic/stocks-healthcare), [$stne](/topic/$stne), [aes](/topic/aes), [$rare](/topic/$rare), [$tnxp](/topic/$tnxp), [$vrna](/topic/$vrna), [$crbu](/topic/$crbu), [$cmps](/topic/$cmps), [$mrk](/topic/$mrk), [qqq](/topic/qqq), [spx](/topic/spx), [alt](/topic/alt), [pltr](/topic/pltr), [$nktr](/topic/$nktr), [$rgnx](/topic/$rgnx), [$qure](/topic/$qure), [insp](/topic/insp), [$hik](/topic/$hik), [telo](/topic/telo), [$vnda](/topic/$vnda), [$akro](/topic/$akro), [$veon](/topic/$veon), [$mgx](/topic/$mgx), [$edit](/topic/$edit), [$capr](/topic/$capr), [stocks](/topic/stocks), [sarepta therapeutics inc](/topic/sarepta-therapeutics-inc), [$dyn](/topic/$dyn), [dec](/topic/dec), [flo](/topic/flo), [manat](/topic/manat), [$grph](/topic/$grph), [$otlk](/topic/$otlk), [$fbio](/topic/$fbio), [$doc](/topic/$doc), [$eras](/topic/$eras), [nvda](/topic/nvda), [$qntm](/topic/$qntm), [$lyel](/topic/$lyel), [$51best](/topic/$51best), [ogn](/topic/ogn), [flr](/topic/flr), [bmi](/topic/bmi), [$talo](/topic/$talo), [$wern](/topic/$wern), [nio](/topic/nio), [$manh](/topic/$manh), [$ewtx](/topic/$ewtx), [$mltx](/topic/$mltx), [$nrix](/topic/$nrix), [$futu](/topic/$futu), [$fsm](/topic/$fsm), [$alks](/topic/$alks), [$krys](/topic/$krys), [$alec](/topic/$alec), [$nvct](/topic/$nvct), [$dtil](/topic/$dtil), [mira](/topic/mira), [amzn](/topic/amzn), [abus](/topic/abus), [$tfinp](/topic/$tfinp), [acquisition](/topic/acquisition), [$ifx](/topic/$ifx), [$nvo](/topic/$nvo), [vir](/topic/vir), [cytk cytokinetics](/topic/cytk-cytokinetics), [$mdnaf](/topic/$mdnaf), [$drug](/topic/$drug), [$gpcr](/topic/$gpcr), [monaco](/topic/monaco), [$bbio](/topic/$bbio), [$pph](/topic/$pph), [$xph](/topic/$xph), [$ibb](/topic/$ibb), [$vktx](/topic/$vktx), [$rovi](/topic/$rovi), [njr](/topic/njr), [eos](/topic/eos), [$naas](/topic/$naas), [$aio](/topic/$aio), [$oec](/topic/$oec), [clsk](/topic/clsk), [$mth](/topic/$mth), [$mcrb](/topic/$mcrb), [tars](/topic/tars), [$vrdn](/topic/$vrdn), [$tars](/topic/$tars), [$lenz](/topic/$lenz), [drugs](/topic/drugs), [val](/topic/val), [$aort](/topic/$aort), [$arow](/topic/$arow), [$1211hk](/topic/$1211hk), [byd](/topic/byd), [$psnl](/topic/$psnl), [$alcy](/topic/$alcy), [$hzo](/topic/$hzo), [$gis](/topic/$gis)

### Top Social Posts [#](/topic/$cytk/posts)
---
Top posts by engagements in the last XX hours

*Showing only X posts for non-authenticated requests. Use your API key in requests for full results.*

"I made $76k today buying stocks on @Yzq_hpp775 's advice.🌻💎 And it worked. Awesome $DTC $TELO $CYCC $BZAI $STEM $LMFA $GCTK $MENS $CYTK $ENTG $OGEN $ANIK $NJR $SUNE $AZN $FLO $IPAR $DEC $PEO $QUAD $DALN $SNPS $PHVS"  
[@kim_stepha88474](/creator/x/kim_stepha88474) on [X](/post/tweet/1946305866153541854) 2025-07-18 20:27:33 UTC X followers, X engagements


"🌺 🎊 🎈 🪐 🎊 I made $17300 this week with the help of @m3m3k45. Their strategy is simple to understand and works great. Awesome $NVDA $TSLA $AMZN $PLTR $AAPL $MIRA $AIRE $NCL $AEBI $XPOF $MINM $MDBH $ZBAO $SCWO $TELO $BZAI $TLN $VLCN $OXLC $BV $CYTK $MARA $EXG"  
[@kEInm_eraphr](/creator/x/kEInm_eraphr) on [X](/post/tweet/1946297449452294169) 2025-07-18 19:54:07 UTC X followers, XXX engagements


"His trading is very accurate @55_i__ I made $80000 in a month by following him to buy stocks.🎊 $CYCC $XAGE $RAPT $CRML $MP $USAR $JUNS $MSGY $FTFT $VBIX $EJH $SLDP $LZMH $IPA $PROK $WKSP $AMPX $JDZG $LIXT $CTOS $HIMS $AMBC $CYTK"  
[@jkbgykh01051592](/creator/x/jkbgykh01051592) on [X](/post/tweet/1946177537652220323) 2025-07-18 11:57:37 UTC X followers, X engagements


"$NVS Novartis CFO on M&A + Not prioritizing Share Buybacks over Bolt-On M&A + Looking at bigger Bolt-On Deals + Have excellent BD and M&A Team + Have $XX Billion Free Cash Flow $XBI $MDGL $BBIO $TGTX $CYTK"  
[@WallStSai](/creator/x/WallStSai) on [X](/post/tweet/1946170474947375193) 2025-07-18 11:29:33 UTC 7058 followers, 6846 engagements